These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28028298)

  • 21. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature.
    Andreoli L; Chighizola CB; Banzato A; Pons-Estel GJ; Ramire de Jesus G; Erkan D
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1869-73. PubMed ID: 23861221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphosphatidylserine antibodies as diagnostic indicators of antiphospholipid syndrome.
    Khogeer H; Alfattani A; Al Kaff M; Al Shehri T; Khojah O; Owaidah T
    Lupus; 2015 Feb; 24(2):186-90. PubMed ID: 25253571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.
    Oku K; Amengual O; Yasuda S; Atsumi T
    Curr Rheumatol Rep; 2017 Aug; 19(8):51. PubMed ID: 28741233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome.
    Ripoll VM; Pregnolato F; Mazza S; Bodio C; Grossi C; McDonnell T; Pericleous C; Meroni PL; Isenberg DA; Rahman A; Giles IP
    J Autoimmun; 2018 Sep; 93():114-123. PubMed ID: 30033000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of antiphospholipid syndrome.
    Tuthill JI; Khamashta MA
    J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
    Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obstetric antiphospholipid syndrome and long term arterial thrombosis risk.
    Drozdinsky G; Hadar E; Shmueli A; Gabbay-Benziv R; Shiber S
    J Thromb Thrombolysis; 2017 Oct; 44(3):371-375. PubMed ID: 28748519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
    Xie H; Sheng L; Zhou H; Yan J
    Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
    van den Hoogen LL; Rossato M; Lopes AP; Pandit A; Bekker CPJ; Fritsch-Stork RDE; van Roon JAG; Radstake TRDJ
    Rheumatology (Oxford); 2018 Sep; 57(9):1669-1674. PubMed ID: 29873766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiphospholipid antibody syndrome].
    Chakoutio V; Ries F
    Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detrimental roles of TNF-alpha in the antiphospholipid syndrome and de novo synthesis of antiphospholipid antibodies induced by biopharmaceuticals against TNF-alpha.
    Bećarević M
    J Thromb Thrombolysis; 2017 Nov; 44(4):565-570. PubMed ID: 29027631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
    Forastiero R; Martinuzzo M
    Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid syndrome (APS): where does it come from?
    Sherer Y; Blank M; Shoenfeld Y
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1071-8. PubMed ID: 18068862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The scoring system for the risk-stratification in patients with the antiphospholipid syndrome].
    Oku K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):435-441. PubMed ID: 29367527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.